27
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of boron neutron capture effects in cell culture using sulforhodamine-B assay and a colony assay

Pages 679-690 | Published online: 03 Jul 2009

  • BEGG, A. C. and MOORE, E., 1989, Rapid fluorescence based assay for radiosensitivity and chemosensitivity testing in mammalian Cells in vitro. Cancer Research, 49, 565-569.
  • BERRY, R. J., EVANS, H. J. and ROBINSON, D. M., 1966, Pertubations in x-ray dose response in Mm with time after plating: a pitfall in the comparison of results obtained by different laboratories using asynchronous cell systems. Experimental Cell Research, 42, 512-522.
  • BURONFOSSB, A., THOMAS, P. C., GINBSTET, C. and DORE, J. F., 1994, Radiosensitivity in vitro of do no genie and nonclonogenic glioblastoma cells obtained from a human brain tumor. Critical Reviews of the Academy of Sciences Paris, 317, 1031-1041.
  • CAPALA, J., MAKAR, M. S. and CODERRE, J. A., 1996, Accumulation of boron in malignant and normal cells incubated in vitro with boronophenylalanine, mercaptoborane or boric acid. Radiation Research, 146, 554-560.
  • CARMICHAEL, J., DE GRAFT, W. G., GAZDAR, A. F., MINNA, J. D. AND MITCHELL, J. B., 1987, Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment Of radiOSensitivity. Cancer Research, 47, 943-946.
  • DURAND, R. E. and SUTHERLAND, R. M., 1972, Effects of intercellular contact on repair of radiation damage. Experimental Cell Research, 71, 75-80.
  • FAIRCHILD, D. W., KAHL, S. B., LASTER, S. H., KALEF EZRA, J. AND POPOENOE, E. A., 1990, In vitro determination of uptake, retention, distribution, biological efficiency, and toxicity of boronated compounds for neutron capture therapy: a comparison of porphyrines with sulfhydryl boron hydrides. Cancer Research, 50, 4860-4865.
  • GABEL, D., 1994, Present status and perspectives of boron neutron Capture therapy. Radiotherapy and Oncology. 30, 199-205.
  • GABBL, D. and PETERS, H.-D., 1997, Treatment of glioma with neutron capture therapy with Na2B12H11SH. Internal Report of the European Collaboration on Boron Neutron Capture Therapy, Summary of the European Phase I toxic ity and pharmacokinetic study, p. 15 (EORTC BNCT Study Group European Organization for Research and Treatment of Cancer (EORTC), Brussels).
  • GABEL, D. and SAUBRWEIN, W., 1995, Approaching clinical trials of boron neutron capture therapy in Europe. 5th International Meeting on Progress in Radio-Oncology IC RO/OG RO 5. In Progress in Radio-O neology V (Monduzzi Editore, Bologna).
  • GRIFFONG., MERLiN9J. L.and MARCHAL9 C., 1995, Comparison of Sulforhodamine-B, tetrazolium and do no genie assays for in vitro radiosensitivity testing in human ovarian cell lines. Anti- Cancer Drugs, 6, 115-123.
  • HATANAKA, H., 1991, Boron-neutron capture therapy for tumors. In Glioma, edited by A. B. M. F. Karim and E. R. Laws (Berlin: Springer), pp. 233-249.
  • KEEPERS, Y. P., PIAZO, P. E., PETERS, G. J., VAN ARK-OTTE, J., WINOGRAD, B. and PINEDO, H. M., 1991, Comparison of the sulforhodamine B protein and tetrazolium (MTT) assay for in vitro chemosensitivity testing. E uropean Jounal of Cancer, 7, 897-900.
  • LARAMORB, G. E., WOOTON, P., LIVESEY, J. C., WILBUR, D. S., RISLER, R., PHILLIPS, M., JACKY, J., BUCHHOLZ, T. A., GRIFFIN, T. W. and BOSSARD, S., 1994, Boron neutron capture therapy: a mechanism for achieving a concomitant tumor boost in fast neutron radiotherapy, international J ournal of Radiation Oncology. Biology. Physics, 28, 1135-1142.
  • OLTHOFF-MUNTER, K. and BAUMHOER, W., 1985, Klinische dosimetrische Eigenschaften von TLD-300-Detektoren und ihre Verwendung zur Messung räumliche Dosisverteilung bei der Patientenbestrahlung. Strahlentherapie, 161, 98-101.
  • PERBZ, R. P., GODWIN, A. K., HANDEL, L. M. and HAMILTON, T. C., 1993, A comparison of clonogenic, microtetrazolium and Sulforhodamine-B assays for determination of cisplatin cytotoxicity in human ovarian carcinoma cell lines. E uropean J ournal of Cancer, 3, 395-399.
  • POLLER, F., BAUCH, T., SAUERWBIN, W., BOCKER, W., WITTIG, A. and STRBFFER, C., 1996, Comet assay study of DNA damage and repair of tumor cells following boron neutron capture irradiation with fast d(14) + Be-neutrons. International Journal of Radiation Biology, 5, 593-602.
  • POLLER, F. and SAUERWEIN, W., 1995, Monte Carlo simulations of the biological effects of boron neutron capture irradiation With d(l4) + Be-neutronS in vitro. Radiation Research, 142, 98-106.
  • POLLBR, F., SAUBRWEIN, W. and RASSOW, J., 1991, Dosimetry and fluence measurements with a new irradiation arrangement for neutron capture therapy of tumors in mice. Radiotherapy and Oncology, 21, 179-182.
  • POLLER, F., SAUERWEIN, W. and RASSOW, J., 1993, Monte Carlo calculation of dose enhancement by neutron capture of 10B Ul fast neutron therapy. Physics in Medicine and Biology, 38, 397-410.
  • POLLMANN, D., BROBKHARD, J. A., LEIS, F., TSCHOFEL, P. and TOLK, G., 1993, Determination of boron in biological tissues by inductively coupled plasma optical emission SpeCtrOSCOpy (ICP-OES). Fresenius, 117, 1-5.
  • ROCKWELL, S., 1985, Effects of clumps and clusters on survival measurements with do no genie assays. Cancer Research, 45, 1601-1607.
  • ROPER, P. R. and DREWINKO, B., 1976, Comparison of in vitro methods to determine drug-induced cell lethality. Cancer Research, 36, 2182-2188.
  • RUBINSTEIN, L. V., SHOEMAKER, R. H., PAULL, K. D., SIMON, R. M., TOSINI, S., SKEHAN, P., SCUDIERO, D. A., MONKS, A. and BOYD, M. R., 1990, Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel Of human tumor Cell lines. Journal of the National Cancer Institute, 82, 1113-1118.
  • SAUERWEIN, W., POLLER, F., RASSOW, J. and SACK, H., 1992, Enhancement of absorbed dose in a d(14)+Be fast neutron beam by 10B neutron capture therapy. In Advanced Radiation Therapy Tumor Response Monitoring and Treatment Planning, edited by A. Breit, A. Heuck, P. Lukas, P. Kneschaurek and M. Meyr (Berlin, New York: Springer Verlag), pp. 797-801.
  • SAUBRWEIN, W., ZIBGLBR, W., SZYPNIBWSKI, H. and STRBFFBR, C., 1990, Boron neutron capture therapy (BNCT) using fast neutrons: effects in two tumor cell lines, strahiemherapie und Onkologie, 116, 26-29.
  • SKEHAN, P., STORENG, R., SCUDIBRO, D., MONKS, A., MCMAHON, J., VISTICA, D., WARREN, J. T., BOKESCH, H., KBNNEY, S. and BOYD, M. R., 1990, New colorimetric cytotoxicity assay for anticancer-drug screening, j ournal of the National Cancer Institute, 82, 1107-1112.
  • SOLOWAY, A. M., ALAM, F., BARTH, F., ANISUZZAMAN, A. K. M. and BAPAT, B. V., 1990, Tumor targeting agents for neutron capture therapy. Basic Life Science, 54, 37-47.
  • SOLOWAY, A. H., BARTH, R. F., TIARKS, W., WYZLIC, I. M., ANISWNZAMAN, A. K. M., 1992, Approaches to design and evaluation of compounds for BNCT. In Boron Neutron Capture Therapy (D. Gabeland R. Moss, Eds.) 223-230 (Plenum Press, New York).
  • TWENTYMAN, P. R., WALLS, O. A. and WRIGHT, K. A., 1984, The response of tumor cells to radiation and cytotoxic drugs -a comparison of colonogenic and isotope uptake assays. British ] ournal of Cancer, 50, 625-631.
  • WASSERMANN, T. H. and TWENTYMAN, P. R., 1988, Use of the colorimetric microtitre (MTT) assay in determining the radiosensitivity of cells from murine solid tumors. International Journal of Radiation Oncology, Biology, Physics, 15, 699-702.
  • WATERMANN, F. M., KUCHNIR, F. T., SKAGGS, L. S., BEWLEY, D. K., PAGE, B. C. and ATTIX, F. H., 1978, The use of 10B to enhance the tumor dose in fast-neutron therapy. Physics in Medicine and Biology, 23, 592-602.
  • WHITMORB, G. F. and TILL, J. E., 1964, Quantitation of cellular radiobiOlOgiCal responses. Annual Review of Nuclear Sciences. 14, 347-374.
  • WILSON, A. P., 1987, In Animal Cell Culture. A Practical Approach, Introduction edited by R. I. Freshney (IRL Press, Oxford, Washington DC).
  • ZHA, X., AUSSBRER, W. A. and MORRISON, G. H., 1992, Quantitative imaging of radiotherapeutic drug Na2B12H11SH at subcellular resolution in tissue cultures USing ion microscopy. Cancer Research, 52, 5219-5222.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.